1. Mizutani, N., Maehara, M., Hayakawa, C., Kato, T., Watanabe, K. and Suzuki, S., Hyperargininemia: Clinical course and treatment with sodium benzoate and phenylacetic acid, Brain and Development 5 (1983) 555–563.
2. Mori, A., Ichimura, T. and Matsumoto, H., Gas chromatography-mass spectrometry of guanidino compounds in brain, Anal. Biochem. 89 (1978) 393–399.
3. Marescau, B., Lowenthal, A., Terheggen, H.G., Esmans, E. and Alderweireldt, F., Guanidino compounds in hyperargininemia, in: “Guanidines”, A. Mori, B.D. Cohen and A. Lowenthal Eds., Plenum Press, New York (1985) pp. 427–434.
4. Marescau, B., Lowenthal, A., Esmans, E., Luyten, Y., Alderweireldt, F. and Terheggen, H.G., Isolation and identification of some guanidino compounds in the urine of patients with hyperargininemia by liquid chromatography, thin-layer chromatography and gas chromatography-mass spectrometry, J. Chromat. 224 (1981) 185–195.
5. Marescau, B., Pintens, J., Lowenthal, A., Esmans, E., Luyten, Y., Lemiere, G., Dommisse, R., Alderweireldt, F. and Terheggen, H.G., Isolation and identification of 2-oxo-5-guanidinovaleric acid in urine of patients with hyperargininemia by chromatography and gas chromatography/ mass spectrometry, J. Clin. Chem. Clin. Biochem. 19 (1981) 61–65.